SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : XOMA. Bull or Bear? -- Ignore unavailable to you. Want to Upgrade?


To: aknahow who wrote (8010)12/11/1998 3:07:00 PM
From: Bluegreen  Respond to of 17367
 
George, the focus is getting fuzzy again! The idea is to prevent sepsis in the beginning or as early as possible. Once vascular damage is done, IT AIN"T COMING BACK! Focus should be helping antibiotics do the rapid killing NOT esoteric theoretical sometimes ridiculous cut and paste discussions of sepsis interruption. Future of this company is based in antibacterial action and hopefully early endotoxin mop up will be gravy. ASK yourself, why Meningo. was picked? Did it have something to do with how well it lends itself to destruction by basic antibiotics? Remember what antibiotic is encouraged to be carried by English clinicians? Do you see why Meningo. is a near perfect fit for testing antibiotic synergistic agent even with Glasglow hurdle set so high? Only my opinions.



To: aknahow who wrote (8010)12/11/1998 3:42:00 PM
From: Bluegreen  Respond to of 17367
 
>>>>>>>HOLLYWOOD, Fla. (AP) -- Joe DiMaggio lapsed into a coma after his lung infection worsened, and his doctor said today that the chances of recovery for the New York Yankees Hall of Famer are ''slim.'' Dr. Earl Barron said the ''overwhelming infection'' in DiMaggio's lungs that has put him near death several times since his surgery Oct. 14 for lung cancer. The 84-year-old baseball great took a turn for the worse in the past 18 hours when pneumonia sent his temperature soaring to 102 degrees, Barron said.<<<<<<<
George, would Neuprex be useful in this case? What happens to WBC's during lung cancer and subsequent chemotherapy? Would it have anything to do with above "overwhelming infection?" Would a clinician use Neuprex here if only indication was for Meningo.?



To: aknahow who wrote (8010)12/11/1998 8:05:00 PM
From: Bluegreen  Read Replies (2) | Respond to of 17367
 
George, could you believe what Murphy said about Xoma on his hotline today? WOW!!!!!!!!!!!!!!!!!!!!!



To: aknahow who wrote (8010)12/11/1998 9:05:00 PM
From: Arthur Radley  Read Replies (1) | Respond to of 17367
 
For all of us with high hopes for our biotech investments:
talks.com